AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device

AtriCure, Inc. (ATRC)  has launched the cryoSPHERE MAX cryoablation probe, which enhances Cryo Nerve Block (cryoNB) therapy by reducing freeze times by 50% compared to previous models and over 30% when compared to the cryoSPHERE+ probe.cryoNB therapy, using AtriCure’s cryoICE technology, is a non-pharmacological method to freeze targeted intercostal nerves, providing temporary pain relief along peripheral nerve pathways.The cryoSPHERE MAX device, part of AtriCure’s cryoNB therapy, cuts ablation time by 50% ...